Literature DB >> 8100129

Comparative pharmacokinetics of diminazene in noninfected Boran (Bos indicus) cattle and Boran cattle infected with Trypanosoma congolense.

M Mamman1, Y O Aliu, A S Peregrine.   

Abstract

The pharmacokinetics of diminazene in five female Boran (Bos indicus) cattle before and then during acute and chronic phases of experimental infections with Trypanosoma congolense were investigated. A 7.0% (wt/vol) solution of diminazene aceturate (Berenil) was used in all three phases of the study and administered as a single intramuscular dose of 3.5 mg of diminazene base per kg of body weight. There were no significant differences between the values of pharmacokinetic parameters for the noninfected cattle and the values for cattle with a chronic T. congolense infection. However, the maximum concentration of the drug in plasma during the acute phase of infection (8.25 +/- 1.72 micrograms/ml) was significantly (P < 0.01) greater than that during chronic infection (5.04 +/- 0.26 micrograms/ml) and that in the noninfected state (4.76 +/- 0.76 micrograms/ml). Similarly, the time to maximum concentration of the drug in plasma when diminazene was administered during the acute phase of infection (18.00 +/- 6.71 min) was significantly (P < 0.02) shorter than that for noninfected cattle (36.00 +/- 8.22 min) and that during chronic infection (33.75 +/- 7.50 min). The volume of distribution at steady state during acute infection (1.01 +/- 0.31 liter/kg) was significantly (P < 0.01) smaller than that in the noninfected state (1.37 +/- 0.17 liter/kg) and that in chronic infection (1.51 +/- 0.24 liter/kg). Eight hours after the drug had been administered, the concentration-time data profiles for each of the three study phases were very similar. Mean concentrations of diminazene in plasma 48 h after administration of the drug were 0.43 +/- 0.07 microgram/ml in noninfected cattle, 0.43 +/- 0.11 microgram/ml during the acute phase of trypanosome infection, and 0.44 +/- 0.09 microgram/ml during the chronic phase of the infection. Results of the present study indicate that the area under the concentration-time curve for diminazene in trypanosome-infected cattle did not differ significantly for noninfected cattle. It, therefore, appears that the total amount of diminazene attained and maintained in the plasma of cattle is not significantly altered during infection with T. congolense.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8100129      PMCID: PMC187894          DOI: 10.1128/AAC.37.5.1050

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

1.  Trypanosoma congolense. I. Clinical observations of experimentally infected cattle.

Authors:  B Wellde; R Lötzsch; G Deindl; E Sadun; J Williams; G Warui
Journal:  Exp Parasitol       Date:  1974-08       Impact factor: 2.011

2.  Kinetics of diphenylhydantoin in uraemic patients: consequences of decreased plasma protein binding.

Authors:  I Odar-Cederlöf; O Borgå
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

3.  An improved parasitological technique for the diagnosis of African trypanosomiasis.

Authors:  M Murray; P K Murray; W I McIntyre
Journal:  Trans R Soc Trop Med Hyg       Date:  1977       Impact factor: 2.184

4.  Susceptibility of inbred strains of mice to Trypanosoma congolense: correlation with changes in spleen lymphocyte populations.

Authors:  W I Morrison; G E Roelants; K S Mayor-Withey; M Murray
Journal:  Clin Exp Immunol       Date:  1978-04       Impact factor: 4.330

5.  Resistance of cattle to tsetse-transmitted challenge with Trypanosoma brucei or Trypanosoma congolense after spontaneous recovery from syringe-passaged infections.

Authors:  V M Nantulya; A J Musoke; F R Rurangirwa; S K Moloo
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

6.  The brain as a source of relapsing Trypanosoma brucei infection in mice after chemotherapy.

Authors:  F W Jennings; D D Whitelaw; P H Holmes; H G Chizyuka; G M Urquhart
Journal:  Int J Parasitol       Date:  1979-08       Impact factor: 3.981

7.  Experimental bovine trypanosomiasis (Trypanosoma vivax and T. congolense). II. Serum levels of total protein, albumin, hemolytic complement, and complement component C3.

Authors:  H Tabel; G J Losos; M G Maxie
Journal:  Tropenmed Parasitol       Date:  1980-03

8.  Pharmacokinetics and efficacy of the trypanocide diminazene aceturate (Berenil) in rabbits.

Authors:  R J Gilbert; B A Newton
Journal:  Vet Rec       Date:  1982-10-23       Impact factor: 2.695

9.  Pharmacokinetic investigations on diminazene and rolitetracycline in comparison to a combination of both.

Authors:  P Klatt; P Hajdu
Journal:  Vet Rec       Date:  1976-11-06       Impact factor: 2.695

10.  Studies in rabbits on the disposition and trypanocidal activity of the anti-trypanosomal drug, diminazene aceturate (Berenil).

Authors:  R J Gilbert
Journal:  Br J Pharmacol       Date:  1983-09       Impact factor: 8.739

View more
  2 in total

1.  Subcellular in vivo 1H MR spectroscopy of Xenopus laevis oocytes.

Authors:  Seung-Cheol Lee; Jee-Hyun Cho; Daniel Mietchen; Young-Sook Kim; Kwan Soo Hong; Chulhyun Lee; Dongmin Kang; Ki Deok Park; Byong-Seok Choi; Chaejoon Cheong
Journal:  Biophys J       Date:  2005-12-16       Impact factor: 4.033

Review 2.  The animal trypanosomiases and their chemotherapy: a review.

Authors:  Federica Giordani; Liam J Morrison; Tim G Rowan; Harry P DE Koning; Michael P Barrett
Journal:  Parasitology       Date:  2016-10-10       Impact factor: 3.234

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.